News
10h
AZoLifeSciences on MSNISGlobal Develops HTGAnalyzer to Simplify Transcriptomic Data AnalysisThe Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, has launched ...
NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...
12h
Dealbreaker on MSNBioNTech to Pay $740M-Plus to Settle mRNA Patent Disputes, Smooth $1.25 Billion DealIn litigation over the past two years, CureVac alleged the BioNTech and Pfizer vaccine for Covid-19 infringed CureVac patents ...
The Department of Health and Human Services announced Thursday that it will cut nearly half a billion dollars in funding for 22 vaccine development programs, many of which ...
The future of mRNA cancer immunotherapies is uncertain after Health and Human Services Secretary Robert F. Kennedy Jr. defunded 22 mRNA vaccine projects for flu and COVID-19.
Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.
"Imagine defunding penicillin research in 1943 because of rare reactions. Absurd, right?" Dr. Jerome Adams wrote on X.
Researchers plan to collaborate on preclinical trials to apply polymersomes to real-world vaccine or drug delivery challenges.
The Barcelona Institute for Global Health (ISGlobal) has launched HTGAnalyzer, a new, easy-to-use, fast and reproducible ...
CureVac (CVAC) and GSK (GSK) to receive $740M and other payments in a settlement with Pfizer (PFE) and BioNTech (BNTX) over ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
When COVID-19 cases were surging, Dr. David Wohl saw patients “hungry for air” fill UNC hospital wards. What most saved lives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results